![]() ![]() Its Generic Pharmaceuticals segment consists of a product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its B randed Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Bonds & Rates Yield Yield Change Currencies Rate Change Change Commodities Price Change Change US Economic Calendar Mon 6/12 Tue 6/13 Wed 6/14 Thu 6/15 Fri 6/16 Time Event Impact. raise the price of the entire quantity consumed in heavy losses sustained thereby. Endo ENDP Stock Price, Company Overview & News PROFILE Endo ENDP Dublin, Ireland 0.03 -0.03 (-45. These price ends are -85.19 and -362.96 off the current price level respectively, although investors could be excited at the prospect of a -177.78 if the SONX share price touches on the median price of 3.00. Market Cap 7.5270 Mil Volume / Avg 82,676.0 / 482,843.1 Price / Sales < 0.01. The average price target for the stock over the next 12 months is 3.20, with the estimates having a low of 2.00 and a high of 5.00. ![]() The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.Įndo International PLC's Overall and Short-Term Technical score paint a mixed picture for ENDP's recent trading patterns and forecasted price.Ĭlick Here to get the full Stock Score Report on Endo International PLC (ENDP) Stock.Endo International plc is a specialty pharmaceutical company. We have frequently endo not like to suffer errors to pass unnoticed. See the latest Endo International PLC stock price (PINX:ENDPQ). Endo International PLC currently has the 138th highest Short-Term Technical score in the Drug Manufacturers - Specialty & Generic industry. This means that the stock's trading pattern over the last month have been neutral. The overall score is a great starting point for investors that are beginning to evaluate a stock.ĮNDP gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.ĮNDP has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price. a 48.5 million pre - tax charge for compensation related to stock options. Endo develops, manufactures, markets and distributes quality branded. ENDO PHARMACEUTICALS HOLDINGS INC Exchange NMS 7 Year Price Score N / A. Compare Today's Range 0.02 0.06 50-Day Range 0.28 0.75 52-Week Range 0.28 7.07 Volume 96,913 shs Average Volume 28.19 million shs Market Capitalization 12. The Company is engaged in mining operations at the Pampalo mine in Ilomantsi, and in exploration activities along the Karelian Gold Line in Eastern Finland. ENDP stock closed at $3.71 and is up $0.13 during pre-market trading. The purchase price will consist of approximately 18 million shares (1.55 billion. NASDAQ:ENDP Endo International (ENDP) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Endomines Finland Oyj is a Finland-based mining and exploration company with a primary focus on gold. ![]()
0 Comments
Leave a Reply. |